PL2651410T3 - Transdermalny system terapeutyczny do podawania substancji czynnej - Google Patents

Transdermalny system terapeutyczny do podawania substancji czynnej

Info

Publication number
PL2651410T3
PL2651410T3 PL11799413T PL11799413T PL2651410T3 PL 2651410 T3 PL2651410 T3 PL 2651410T3 PL 11799413 T PL11799413 T PL 11799413T PL 11799413 T PL11799413 T PL 11799413T PL 2651410 T3 PL2651410 T3 PL 2651410T3
Authority
PL
Poland
Prior art keywords
administering
active substance
therapeutic system
transdermal therapeutic
transdermal
Prior art date
Application number
PL11799413T
Other languages
English (en)
Inventor
Britta Langer
Bjoern Schurad
Heike Prinz
Original Assignee
Luye Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luye Pharma Ag filed Critical Luye Pharma Ag
Publication of PL2651410T3 publication Critical patent/PL2651410T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL11799413T 2010-12-14 2011-12-14 Transdermalny system terapeutyczny do podawania substancji czynnej PL2651410T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10194968.3A EP2468274B1 (de) 2010-12-14 2010-12-14 Transdermales therapeutisches System zur Verabreichung eines Wirkstoffs
EP11799413.7A EP2651410B1 (de) 2010-12-14 2011-12-14 Transdermales therapeutisches system zur verabreichung eines wirkstoffs
PCT/EP2011/072812 WO2012080365A1 (de) 2010-12-14 2011-12-14 Transdermales therapeutisches system zur verabreichung eines wirkstoffs

Publications (1)

Publication Number Publication Date
PL2651410T3 true PL2651410T3 (pl) 2021-03-08

Family

ID=43836835

Family Applications (2)

Application Number Title Priority Date Filing Date
PL10194968T PL2468274T3 (pl) 2010-12-14 2010-12-14 Przezskórny układ terapeutyczny do podawania substancji czynnej
PL11799413T PL2651410T3 (pl) 2010-12-14 2011-12-14 Transdermalny system terapeutyczny do podawania substancji czynnej

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL10194968T PL2468274T3 (pl) 2010-12-14 2010-12-14 Przezskórny układ terapeutyczny do podawania substancji czynnej

Country Status (25)

Country Link
US (2) US10660863B2 (pl)
EP (2) EP2468274B1 (pl)
JP (1) JP6043296B2 (pl)
KR (1) KR101842309B1 (pl)
CN (3) CN103269698B (pl)
AU (2) AU2011343363B2 (pl)
BR (1) BR112013014616B1 (pl)
CA (2) CA2817461C (pl)
CY (2) CY1116638T1 (pl)
DK (2) DK2468274T3 (pl)
EA (1) EA026520B1 (pl)
ES (2) ES2545094T3 (pl)
HK (1) HK1243336A1 (pl)
HR (2) HRP20201880T1 (pl)
HU (2) HUE027916T2 (pl)
LT (1) LT2651410T (pl)
MX (1) MX345344B (pl)
MY (1) MY183873A (pl)
PL (2) PL2468274T3 (pl)
PT (2) PT2468274E (pl)
RS (2) RS54173B1 (pl)
SI (2) SI2468274T1 (pl)
SM (2) SMT202000638T1 (pl)
WO (1) WO2012080365A1 (pl)
ZA (1) ZA201303965B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012000369A1 (de) * 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
DE102012016317A1 (de) 2012-08-14 2014-02-20 Jenabatteries GmbH Redox-Flow-Zelle zur Speicherung elektrischer Energie
CN104582693A (zh) * 2012-08-15 2015-04-29 道康宁公司 多层药物递送系统
WO2014111790A2 (en) * 2013-01-15 2014-07-24 Zydus Technologies Limited Stable transdermal pharmaceutical drug delivery system comprising rivastigmine
US20240082065A1 (en) * 2016-07-08 2024-03-14 Moteah Williams Waterproof and transparent wound barrier and method of manufacturing same
CN109640976B (zh) 2016-08-22 2023-10-17 救急药品工业株式会社 贴附剂
US12290501B2 (en) * 2017-07-19 2025-05-06 Teikoku Seiyaku Co., Ltd. Rivastigmine-containing transdermal absorption preparation
DE102018120506A1 (de) * 2017-10-20 2019-04-25 Amw Gmbh Stabilisiertes transdermales Darreichungssystem
DE102017127433A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices
US20210038532A1 (en) * 2018-03-13 2021-02-11 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system comprising a silicone acrylic hybrid polymer
WO2019220697A1 (ja) * 2018-05-17 2019-11-21 パナソニックＩｐマネジメント株式会社 生体貼付け用選択透過膜、経皮吸収キットおよび美容方法
DK3513965T3 (da) 2018-08-08 2022-07-25 Danapak Flexibles As Forbedrede film og laminater til anvendelse i pakning af reaktive forbindelser
KR102710072B1 (ko) 2018-08-31 2024-09-24 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
KR102823139B1 (ko) 2018-08-31 2025-06-19 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
BR112021023509A2 (pt) * 2019-07-09 2022-01-18 Lts Lohmann Therapie Systeme Ag Sistema terapêutico transdérmico compreendendo uma camada contendo o agente ativo compreendendo um polímero acrílico e uma camada de contato com a pele compreendendo um adesivo de gel de silicone
CN113616625B (zh) * 2021-08-26 2023-05-30 大连科翔科技开发有限公司 一种卡巴拉汀的长效透皮贴剂
DE102021128912A1 (de) * 2021-11-05 2023-05-11 Lts Lohmann Therapie-Systeme Ag. Okklusives pflaster mit flexibler backing

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL195004C (nl) 1987-03-04 2003-11-04 Novartis Ag Fenylcarbamaat bevattend farmaceutisch preparaat.
CA2142871A1 (en) * 1992-08-25 1994-03-03 Jesus Miranda Printed transdermal drug delivery device
JPH0912448A (ja) * 1995-04-28 1997-01-14 Read Chem Kk 薬物放出制御型経皮吸収製剤
GB9800526D0 (en) 1998-01-12 1998-03-11 Ciba Geigy Ag Organic compounds
US6348210B1 (en) * 1998-11-13 2002-02-19 Alza Corporation Methods for transdermal drug administration
DE19918106A1 (de) 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
DE10033853A1 (de) 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
DE10103860B4 (de) * 2001-01-30 2004-12-23 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung
DE10141652B4 (de) 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US8252319B2 (en) * 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
SI1814531T1 (sl) * 2004-10-21 2010-10-29 Durect Corp Transdermalni dostavni sistem
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
CA2634975A1 (en) * 2005-12-30 2007-07-12 Coloplast A/S A layered adhesive construct having a mouldable layer as skin contact surface
CN101304735A (zh) * 2006-01-12 2008-11-12 Lts勒曼治疗系统股份公司 用于挥发性和/或热不稳定的物质的经皮治疗体系
MY149152A (en) 2006-05-08 2013-07-15 Teikoku Seiyaku Kk Percutaneous absorption preparations of antimentia drugs
US9248104B2 (en) 2006-08-17 2016-02-02 Core Tech Solutions, Inc. Transdermal methods and systems for treating Alzheimer's disease
DE102006054731B4 (de) * 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
WO2009009651A1 (en) 2007-07-10 2009-01-15 Agile Therapeutics, Inc. Dermal delivery device with ultrasonic weld
WO2009026135A2 (en) * 2007-08-17 2009-02-26 Alza Corporation Controlled transdermal bisoprolol delivery system
US9155725B2 (en) * 2008-02-27 2015-10-13 Hisamitsu Pharmaceutical Co., Inc. Adhesive skin patch and packaged product
US20090291127A1 (en) * 2008-05-21 2009-11-26 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
JP2010126450A (ja) * 2008-11-25 2010-06-10 Lintec Corp 経皮吸収貼付剤
BR112012017168B1 (pt) * 2009-12-22 2022-03-15 Luye Pharma Ag Sistemas terapêuticos transdérmicos, seu processo de preparação, e usos de um polímero ou copolímero

Also Published As

Publication number Publication date
CA3065240C (en) 2022-02-15
ZA201303965B (en) 2014-09-25
JP2014503523A (ja) 2014-02-13
AU2011343363B2 (en) 2017-06-08
AU2011343363A1 (en) 2013-06-20
CY1123712T1 (el) 2022-03-24
EP2651410A1 (de) 2013-10-23
SI2651410T1 (sl) 2021-01-29
LT2651410T (lt) 2020-12-28
MX345344B (es) 2017-01-26
PT2651410T (pt) 2020-12-15
US10660863B2 (en) 2020-05-26
PT2468274E (pt) 2015-09-21
EP2651410B1 (de) 2020-10-14
CA3065240A1 (en) 2012-06-21
US20200289426A1 (en) 2020-09-17
CY1116638T1 (el) 2017-03-15
BR112013014616A2 (pt) 2016-09-20
BR112013014616B1 (pt) 2021-12-21
CN113244199A (zh) 2021-08-13
HRP20150881T1 (hr) 2015-09-25
EP2468274A1 (de) 2012-06-27
DK2651410T3 (da) 2020-11-02
CA2817461C (en) 2020-02-25
HUE027916T2 (en) 2016-11-28
HK1243336A1 (zh) 2018-07-13
ES2545094T3 (es) 2015-09-08
AU2017213569B2 (en) 2019-04-11
KR20130129988A (ko) 2013-11-29
RS61155B1 (sr) 2020-12-31
WO2012080365A1 (de) 2012-06-21
US20140323996A1 (en) 2014-10-30
MX2013005581A (es) 2013-08-26
CA2817461A1 (en) 2012-06-21
EA201300704A1 (ru) 2014-01-30
DK2468274T3 (en) 2015-08-31
ES2836483T3 (es) 2021-06-25
CN103269698A (zh) 2013-08-28
KR101842309B1 (ko) 2018-03-26
JP6043296B2 (ja) 2016-12-14
SMT201500184B (it) 2015-09-07
SMT202000638T1 (it) 2021-01-05
PL2468274T3 (pl) 2015-11-30
EP2468274B1 (de) 2015-07-01
EA026520B1 (ru) 2017-04-28
HUE052137T2 (hu) 2021-04-28
SI2468274T1 (sl) 2015-10-30
RS54173B1 (sr) 2015-12-31
MY183873A (en) 2021-03-17
HRP20201880T1 (hr) 2021-02-05
AU2017213569A1 (en) 2017-08-31
CN103269698B (zh) 2017-07-14
CN107412202A (zh) 2017-12-01

Similar Documents

Publication Publication Date Title
ZA201303965B (en) Transdermal therapeutic system for administering an active substance
PL2560624T3 (pl) Formulacja terapeutyczna do zmniejszania skutków ubocznych leku
PT2726141T (pt) Dispositivo para administração oral de compostos terapêuticos
PL2515886T3 (pl) Przezskórny układ terapeutyczny do podawania rywastygminy lub jej pochodnych
SMT201500232B (it) Dispositivo per la somministrazione de farmaci
PT2600812T (pt) Aparelho para tratar um olho
PL3023120T3 (pl) Aparaty do podawania leków przez skórę
EP2720748A4 (en) TRANSDERMAL DRUG DELIVERY SYSTEM AND METHOD OF USE THEREOF
IL221412A (en) Urine drug delivery system
ZA201208646B (en) Pharmaceutical combination for the treatment of pain
IL225438A0 (en) Use of active pharmaceutical compounds to treat disorders of the central nervous system
PL2773648T3 (pl) Związki farmaceutyczne do zastosowania w terapii zakażenia clostridium difficile
EP2538913A4 (en) Device and system for determining, preparing and administering therapeutically effective doses
ZA201403497B (en) Transdermal therapeutic system for administering fentanyl or analogue thereof
PL2750673T3 (pl) Transdermalny system terapeutyczny dla chlorowodorku kwasu 5-aminolewulinowego
ZA201301458B (en) Therapeutic agent for pain
AP3390A (en) Therapeutic vaccination against active tuberculosis
IL221713A (en) An apparatus for delivering medicinal products through endovascular infusion
PT2566579E (pt) Dispositivo médico para magnetoterapia
EP2485719A4 (en) TRANSDERMAL THERAPEUTIC SYSTEM
EP2578199A4 (en) UNIDOSE PACKAGING FOR MEDICAMENTS
TWM401446U (en) Skin therapy device structure
HK1202239A1 (en) Combination drug therapy for the treatment of solid tumors
PL395455A1 (pl) Urzadzenie medyczne do czasowej elektrostymulacji serca
SI2613772T1 (sl) Transdermalni obliži z nizkim odmerkom z visoko stopnjo sproščanja zdravila